| 1.9 |
13.4 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 1.6 |
4.9 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 1.4 |
1.4 |
GO:1903923 |
protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 1.4 |
4.2 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 1.4 |
4.1 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 1.4 |
5.5 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 1.3 |
4.0 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 1.3 |
3.9 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.3 |
3.9 |
GO:2001037 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 1.2 |
3.7 |
GO:0006535 |
cysteine biosynthetic process from serine(GO:0006535) |
| 1.2 |
3.6 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.2 |
12.9 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 1.0 |
3.0 |
GO:0003169 |
coronary vein morphogenesis(GO:0003169) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.0 |
1.0 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 1.0 |
4.0 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 1.0 |
5.9 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.9 |
1.9 |
GO:0060221 |
retinal rod cell differentiation(GO:0060221) |
| 0.9 |
0.9 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.9 |
3.6 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.9 |
2.7 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.9 |
1.8 |
GO:2000705 |
dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.9 |
2.7 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.9 |
3.5 |
GO:2000230 |
negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.9 |
3.5 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.9 |
5.2 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.9 |
2.6 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.9 |
5.1 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.8 |
7.6 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.8 |
4.2 |
GO:1902378 |
vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.8 |
2.5 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 0.8 |
2.4 |
GO:2000309 |
activation of MAPK activity involved in innate immune response(GO:0035419) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 0.8 |
2.4 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 0.8 |
2.4 |
GO:0006154 |
adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 0.8 |
2.4 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.8 |
3.2 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.8 |
3.2 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.8 |
3.1 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.8 |
1.5 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.8 |
6.0 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.8 |
2.3 |
GO:0051780 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.8 |
0.8 |
GO:1903202 |
negative regulation of oxidative stress-induced cell death(GO:1903202) |
| 0.7 |
9.0 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.7 |
3.0 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.7 |
2.2 |
GO:0036486 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.7 |
2.2 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.7 |
4.3 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.7 |
2.2 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 0.7 |
1.4 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.7 |
3.6 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 0.7 |
7.1 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.7 |
4.3 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.7 |
2.1 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.7 |
4.2 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.7 |
6.8 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.7 |
4.0 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.7 |
3.3 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.7 |
2.6 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.6 |
4.5 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.6 |
0.6 |
GO:0046102 |
inosine metabolic process(GO:0046102) |
| 0.6 |
2.5 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.6 |
0.6 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.6 |
0.6 |
GO:0021898 |
commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.6 |
2.4 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.6 |
0.6 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.6 |
1.8 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.6 |
0.6 |
GO:0014740 |
negative regulation of muscle hyperplasia(GO:0014740) |
| 0.6 |
3.5 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.6 |
2.9 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.6 |
1.7 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.6 |
0.6 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.6 |
1.7 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.6 |
0.6 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.6 |
1.7 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 0.6 |
3.9 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.5 |
1.6 |
GO:0031938 |
regulation of chromatin silencing at telomere(GO:0031938) |
| 0.5 |
4.9 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.5 |
1.1 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.5 |
5.9 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.5 |
0.5 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.5 |
1.6 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.5 |
2.7 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.5 |
1.6 |
GO:0005988 |
lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.5 |
1.6 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.5 |
4.2 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.5 |
1.6 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.5 |
2.1 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.5 |
2.6 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.5 |
0.5 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 0.5 |
3.6 |
GO:0021842 |
directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.5 |
2.5 |
GO:0090402 |
oncogene-induced cell senescence(GO:0090402) |
| 0.5 |
2.0 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.5 |
3.0 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.5 |
4.5 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.5 |
1.5 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.5 |
8.0 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 |
1.5 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.5 |
6.4 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.5 |
2.5 |
GO:0007070 |
negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.5 |
1.0 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.5 |
1.5 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.5 |
2.4 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 0.5 |
1.5 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.5 |
1.4 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 0.5 |
1.4 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.5 |
5.7 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.5 |
1.4 |
GO:0050894 |
determination of affect(GO:0050894) |
| 0.5 |
2.4 |
GO:0031959 |
mineralocorticoid receptor signaling pathway(GO:0031959) |
| 0.5 |
1.9 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.5 |
1.4 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.5 |
4.2 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.5 |
1.4 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.5 |
1.4 |
GO:0008344 |
adult locomotory behavior(GO:0008344) |
| 0.5 |
1.8 |
GO:0035625 |
epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.5 |
0.9 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.4 |
2.2 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.4 |
2.7 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.4 |
3.1 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.4 |
4.4 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.4 |
1.3 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.4 |
3.9 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.4 |
2.6 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 0.4 |
1.3 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.4 |
2.6 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.4 |
0.4 |
GO:0051125 |
regulation of actin nucleation(GO:0051125) |
| 0.4 |
1.7 |
GO:0019860 |
uracil metabolic process(GO:0019860) |
| 0.4 |
4.7 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.4 |
1.3 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.4 |
1.3 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.4 |
2.5 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.4 |
1.3 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.4 |
2.1 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.4 |
1.3 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.4 |
12.1 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.4 |
1.7 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 |
0.8 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.4 |
1.2 |
GO:1902019 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.4 |
1.2 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.4 |
1.6 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.4 |
1.2 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.4 |
1.2 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.4 |
1.2 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.4 |
0.8 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.4 |
5.2 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.4 |
1.2 |
GO:1904717 |
excitatory chemical synaptic transmission(GO:0098976) positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.4 |
5.6 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.4 |
2.0 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.4 |
8.8 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.4 |
0.8 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 |
0.8 |
GO:1902949 |
positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.4 |
1.2 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.4 |
2.0 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.4 |
1.2 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.4 |
0.4 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.4 |
1.6 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.4 |
1.2 |
GO:0031064 |
negative regulation of histone deacetylation(GO:0031064) |
| 0.4 |
1.2 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.4 |
1.6 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.4 |
2.3 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.4 |
1.2 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.4 |
1.5 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.4 |
1.5 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.4 |
1.5 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.4 |
0.4 |
GO:0090149 |
mitochondrial membrane fission(GO:0090149) |
| 0.4 |
1.5 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.4 |
1.5 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 0.4 |
9.9 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.4 |
2.3 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.4 |
1.1 |
GO:0086098 |
angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 0.4 |
0.4 |
GO:1900111 |
positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.4 |
3.0 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.4 |
3.8 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.4 |
0.4 |
GO:2000410 |
regulation of thymocyte migration(GO:2000410) |
| 0.4 |
3.8 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.4 |
5.6 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.4 |
9.6 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.4 |
3.3 |
GO:0032966 |
negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.4 |
4.7 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.4 |
5.8 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.4 |
2.9 |
GO:0010767 |
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.4 |
1.8 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.4 |
1.5 |
GO:1905123 |
regulation of glucosylceramidase activity(GO:1905123) |
| 0.4 |
2.2 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.4 |
0.7 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.4 |
1.1 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.4 |
1.1 |
GO:1902869 |
regulation of amacrine cell differentiation(GO:1902869) |
| 0.4 |
1.4 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.4 |
0.4 |
GO:0072014 |
proximal tubule development(GO:0072014) |
| 0.3 |
1.0 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.3 |
0.3 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.3 |
1.4 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.3 |
0.3 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.3 |
0.3 |
GO:1901895 |
negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.3 |
3.1 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.3 |
1.0 |
GO:0010887 |
negative regulation of cholesterol storage(GO:0010887) |
| 0.3 |
1.0 |
GO:1903527 |
regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.3 |
2.7 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.3 |
0.3 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.3 |
2.7 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.3 |
1.4 |
GO:0070981 |
L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.3 |
1.4 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.3 |
0.3 |
GO:0050807 |
regulation of synapse organization(GO:0050807) |
| 0.3 |
1.0 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.3 |
1.0 |
GO:0043397 |
corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.3 |
1.7 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.3 |
1.3 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.3 |
0.7 |
GO:1904170 |
regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 0.3 |
1.0 |
GO:0044771 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.3 |
1.3 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.3 |
0.7 |
GO:0042552 |
myelination(GO:0042552) |
| 0.3 |
5.6 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.3 |
1.0 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.3 |
1.0 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.3 |
1.6 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.3 |
0.3 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.3 |
1.0 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 0.3 |
1.3 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.3 |
0.6 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.3 |
1.9 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.3 |
4.8 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.3 |
3.5 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.3 |
5.1 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.3 |
1.6 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.3 |
4.8 |
GO:1904778 |
regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.3 |
0.6 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.3 |
0.9 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.3 |
0.3 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.3 |
1.9 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.3 |
1.2 |
GO:0070813 |
hydrogen sulfide metabolic process(GO:0070813) |
| 0.3 |
1.9 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.3 |
0.9 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.3 |
1.6 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.3 |
1.2 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.3 |
0.3 |
GO:1901860 |
positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.3 |
1.2 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.3 |
1.2 |
GO:0017198 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 |
0.9 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.3 |
1.2 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.3 |
2.1 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.3 |
1.5 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.3 |
0.3 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.3 |
2.4 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.3 |
0.9 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 0.3 |
0.3 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.3 |
2.7 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.3 |
1.8 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.3 |
0.3 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 0.3 |
2.9 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.3 |
0.6 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.3 |
1.1 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.3 |
0.3 |
GO:1905166 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.3 |
0.3 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.3 |
0.3 |
GO:0045645 |
regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.3 |
1.1 |
GO:0001188 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.3 |
0.3 |
GO:0001710 |
mesodermal cell fate commitment(GO:0001710) |
| 0.3 |
1.1 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.3 |
0.6 |
GO:0035909 |
aorta morphogenesis(GO:0035909) |
| 0.3 |
1.4 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.3 |
0.6 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.3 |
2.2 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 0.3 |
1.1 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.3 |
0.3 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.3 |
1.4 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 |
1.1 |
GO:0021557 |
optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) |
| 0.3 |
1.4 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.3 |
1.6 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 0.3 |
1.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.3 |
1.6 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.3 |
1.1 |
GO:0071484 |
cellular response to light intensity(GO:0071484) |
| 0.3 |
1.3 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.3 |
1.1 |
GO:0042418 |
epinephrine biosynthetic process(GO:0042418) |
| 0.3 |
0.3 |
GO:0071362 |
cellular response to ether(GO:0071362) |
| 0.3 |
0.3 |
GO:0086028 |
bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.3 |
0.8 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.3 |
0.3 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.3 |
1.3 |
GO:1904744 |
positive regulation of telomeric DNA binding(GO:1904744) |
| 0.3 |
1.3 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.3 |
0.8 |
GO:1903431 |
positive regulation of cell maturation(GO:1903431) |
| 0.3 |
0.8 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.3 |
1.6 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.3 |
1.8 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.3 |
1.3 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.3 |
0.8 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.3 |
3.3 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.3 |
0.8 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 |
1.5 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.3 |
0.3 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.3 |
2.8 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.3 |
1.3 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.2 |
0.5 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.2 |
0.5 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.2 |
12.1 |
GO:0061620 |
glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.2 |
4.9 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) |
| 0.2 |
0.5 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.2 |
0.2 |
GO:0051938 |
L-glutamate import(GO:0051938) |
| 0.2 |
0.5 |
GO:0007622 |
rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
| 0.2 |
0.7 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.2 |
0.7 |
GO:0090259 |
regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.2 |
0.2 |
GO:1904783 |
positive regulation of NMDA glutamate receptor activity(GO:1904783) |
| 0.2 |
0.7 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.2 |
0.7 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.2 |
4.8 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.2 |
3.1 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.2 |
0.2 |
GO:0090003 |
regulation of establishment of protein localization to plasma membrane(GO:0090003) |
| 0.2 |
1.2 |
GO:0072069 |
DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.2 |
0.5 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.2 |
1.2 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.2 |
0.7 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.2 |
0.7 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.2 |
1.7 |
GO:0043622 |
cortical microtubule organization(GO:0043622) |
| 0.2 |
3.3 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.2 |
0.2 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.2 |
1.6 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.2 |
6.1 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.2 |
0.2 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.2 |
1.6 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 |
1.9 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.2 |
0.9 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.2 |
1.6 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.2 |
1.2 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.2 |
3.7 |
GO:0051608 |
histamine transport(GO:0051608) |
| 0.2 |
0.7 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 |
0.5 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 |
1.2 |
GO:0003342 |
proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.2 |
1.8 |
GO:0046618 |
drug export(GO:0046618) |
| 0.2 |
0.7 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.2 |
0.2 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.2 |
0.7 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.2 |
1.8 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
0.5 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.2 |
1.1 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.2 |
1.8 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 |
2.0 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 |
0.4 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.2 |
3.4 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 |
0.7 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 0.2 |
2.7 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.2 |
0.9 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 0.2 |
0.4 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.2 |
1.1 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.2 |
0.2 |
GO:0010635 |
regulation of mitochondrial fusion(GO:0010635) negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
1.5 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 |
0.7 |
GO:0098759 |
response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.2 |
0.2 |
GO:0060585 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.2 |
1.7 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.2 |
0.2 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 |
0.7 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.2 |
5.4 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.2 |
0.9 |
GO:1900114 |
positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 0.2 |
0.2 |
GO:1903223 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.2 |
1.7 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.2 |
0.4 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.2 |
0.4 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.2 |
0.2 |
GO:0006971 |
hypotonic response(GO:0006971) |
| 0.2 |
0.6 |
GO:0006500 |
N-terminal protein palmitoylation(GO:0006500) |
| 0.2 |
0.6 |
GO:0031660 |
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 0.2 |
1.3 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.2 |
1.5 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.2 |
0.6 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 |
0.2 |
GO:1990869 |
response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.2 |
0.2 |
GO:0051932 |
synaptic transmission, GABAergic(GO:0051932) |
| 0.2 |
0.6 |
GO:0003358 |
noradrenergic neuron development(GO:0003358) |
| 0.2 |
0.2 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.2 |
1.0 |
GO:0061767 |
negative regulation of lung blood pressure(GO:0061767) |
| 0.2 |
2.3 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.2 |
1.0 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.2 |
1.7 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.2 |
1.2 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.2 |
0.4 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 |
1.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.2 |
1.0 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.2 |
0.8 |
GO:1901662 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.2 |
1.7 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.2 |
1.6 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.2 |
1.2 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.2 |
0.2 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 0.2 |
0.8 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.2 |
1.2 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.2 |
1.8 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.2 |
4.9 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.2 |
1.2 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.2 |
0.6 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.2 |
1.6 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.2 |
4.4 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 |
0.6 |
GO:0046073 |
dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.2 |
0.6 |
GO:0035623 |
regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
| 0.2 |
0.6 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 |
0.6 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.2 |
2.6 |
GO:0010867 |
positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.2 |
3.8 |
GO:0035589 |
G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.2 |
1.6 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.2 |
0.8 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.2 |
0.6 |
GO:0098912 |
membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.2 |
1.2 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.2 |
1.0 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.2 |
0.2 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.2 |
0.4 |
GO:1904098 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.2 |
2.2 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.2 |
2.5 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.2 |
1.2 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 |
3.5 |
GO:0046629 |
gamma-delta T cell activation(GO:0046629) |
| 0.2 |
0.6 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.2 |
1.9 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 |
1.0 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.2 |
0.2 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.2 |
0.8 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.2 |
2.9 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
2.7 |
GO:0046051 |
UTP metabolic process(GO:0046051) |
| 0.2 |
1.7 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.2 |
0.8 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
3.1 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.2 |
1.5 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.2 |
0.4 |
GO:1905049 |
negative regulation of metallopeptidase activity(GO:1905049) |
| 0.2 |
2.7 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 |
0.2 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.2 |
1.1 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 |
1.0 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.2 |
2.3 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 |
0.9 |
GO:0002543 |
activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.2 |
0.2 |
GO:0070305 |
response to cGMP(GO:0070305) |
| 0.2 |
1.7 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
1.1 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.2 |
0.9 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
1.1 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.2 |
0.4 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.2 |
0.6 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 |
0.9 |
GO:0060390 |
regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.2 |
1.7 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 |
2.8 |
GO:0030540 |
female genitalia development(GO:0030540) |
| 0.2 |
0.7 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.2 |
0.6 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.2 |
2.2 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.2 |
1.8 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 |
0.9 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 |
3.9 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 |
0.7 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.2 |
0.4 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.2 |
1.8 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.2 |
0.9 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 |
2.8 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.2 |
0.9 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.2 |
0.2 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.2 |
1.1 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.2 |
0.4 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.2 |
0.7 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.2 |
1.6 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.2 |
1.8 |
GO:0042759 |
long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.2 |
0.5 |
GO:1990258 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.2 |
0.7 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.2 |
1.1 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.2 |
0.9 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 |
0.9 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.2 |
0.5 |
GO:0019285 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.2 |
0.4 |
GO:0060027 |
convergent extension involved in gastrulation(GO:0060027) |
| 0.2 |
0.7 |
GO:0021564 |
vagus nerve development(GO:0021564) |
| 0.2 |
0.4 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.2 |
0.5 |
GO:0071790 |
spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.2 |
0.7 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.2 |
0.5 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.2 |
1.2 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.2 |
0.7 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.2 |
1.9 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 |
2.3 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.2 |
1.1 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
1.1 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.2 |
1.9 |
GO:1904322 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.2 |
1.4 |
GO:0035524 |
proline transmembrane transport(GO:0035524) |
| 0.2 |
0.7 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 |
0.9 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 |
2.1 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.2 |
0.7 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.2 |
2.6 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 |
0.7 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.2 |
0.5 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.2 |
0.8 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 |
1.2 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
| 0.2 |
0.5 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 |
0.2 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.2 |
0.2 |
GO:0010996 |
response to auditory stimulus(GO:0010996) |
| 0.2 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.2 |
3.2 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.2 |
0.2 |
GO:0099543 |
retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 0.2 |
0.8 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
0.2 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.2 |
0.3 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.2 |
0.3 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.2 |
1.5 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.2 |
1.0 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.2 |
0.2 |
GO:0051971 |
positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.2 |
0.5 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.2 |
0.5 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.2 |
3.1 |
GO:0010919 |
regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.2 |
1.8 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
0.6 |
GO:0042853 |
L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.2 |
1.3 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 0.2 |
3.9 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.2 |
1.3 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.2 |
0.6 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
0.6 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.2 |
1.1 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.2 |
0.3 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.2 |
0.2 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.2 |
0.6 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.2 |
0.5 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.2 |
0.8 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 |
0.2 |
GO:0090427 |
activation of meiosis(GO:0090427) |
| 0.2 |
0.6 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
0.5 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.2 |
0.2 |
GO:1903756 |
regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.2 |
0.9 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.2 |
0.8 |
GO:0051461 |
positive regulation of corticotropin secretion(GO:0051461) |
| 0.2 |
0.6 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.2 |
0.6 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 |
0.3 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.1 |
4.3 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.1 |
0.1 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
| 0.1 |
0.1 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 0.1 |
0.7 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 |
1.0 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.1 |
0.9 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.1 |
0.4 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.1 |
2.2 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.1 |
0.4 |
GO:0090128 |
regulation of synapse maturation(GO:0090128) |
| 0.1 |
5.7 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 |
0.9 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.1 |
0.1 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 |
1.2 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.1 |
0.3 |
GO:0060490 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.1 |
0.6 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 |
0.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.1 |
GO:0071306 |
cellular response to vitamin E(GO:0071306) |
| 0.1 |
0.7 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 |
4.2 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 |
0.4 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.3 |
GO:2001201 |
regulation of transforming growth factor-beta secretion(GO:2001201) |
| 0.1 |
0.3 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.1 |
0.3 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.1 |
0.3 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 |
0.8 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
0.6 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.1 |
0.7 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.3 |
GO:0033602 |
negative regulation of dopamine secretion(GO:0033602) |
| 0.1 |
0.3 |
GO:0070859 |
positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.1 |
0.8 |
GO:1901908 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.1 |
0.4 |
GO:0044728 |
DNA methylation or demethylation(GO:0044728) |
| 0.1 |
1.8 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 |
0.3 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.7 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
0.4 |
GO:0045359 |
positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.1 |
0.7 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.1 |
0.4 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.1 |
1.0 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.1 |
0.4 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.1 |
0.5 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.1 |
0.3 |
GO:0003285 |
septum secundum development(GO:0003285) |
| 0.1 |
0.1 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.1 |
0.3 |
GO:0006554 |
lysine catabolic process(GO:0006554) |
| 0.1 |
1.1 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.3 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.1 |
0.1 |
GO:0035470 |
positive regulation of vascular wound healing(GO:0035470) |
| 0.1 |
2.6 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.1 |
0.1 |
GO:0051136 |
regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
1.2 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 |
0.7 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.1 |
1.1 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.1 |
0.3 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.1 |
2.0 |
GO:0042167 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 |
0.4 |
GO:0032707 |
negative regulation of interleukin-23 production(GO:0032707) |
| 0.1 |
0.1 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.1 |
0.5 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.1 |
0.3 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 |
0.9 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.1 |
0.8 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.1 |
0.8 |
GO:0002090 |
regulation of receptor internalization(GO:0002090) |
| 0.1 |
1.4 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.1 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.1 |
1.0 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.9 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.6 |
GO:0019470 |
4-hydroxyproline catabolic process(GO:0019470) |
| 0.1 |
0.5 |
GO:2001295 |
malonyl-CoA biosynthetic process(GO:2001295) |
| 0.1 |
0.1 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
0.4 |
GO:0043574 |
peroxisomal transport(GO:0043574) |
| 0.1 |
0.3 |
GO:0060823 |
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 |
0.4 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.1 |
1.1 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.1 |
0.5 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
0.1 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.1 |
0.1 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
| 0.1 |
0.3 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.1 |
1.6 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 |
1.0 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.1 |
1.3 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 |
0.3 |
GO:0016103 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.1 |
0.1 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 |
0.1 |
GO:0030204 |
chondroitin sulfate metabolic process(GO:0030204) chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
| 0.1 |
0.4 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.1 |
0.6 |
GO:0050916 |
sensory perception of sweet taste(GO:0050916) |
| 0.1 |
0.8 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.1 |
0.8 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 |
0.8 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.4 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.1 |
1.4 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.1 |
GO:1902668 |
negative regulation of axon guidance(GO:1902668) |
| 0.1 |
1.9 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.2 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.1 |
0.7 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.1 |
0.5 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 |
0.5 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
1.6 |
GO:0001946 |
lymphangiogenesis(GO:0001946) |
| 0.1 |
0.1 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.1 |
3.8 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 |
0.4 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.1 |
0.1 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
0.9 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
0.7 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.1 |
0.1 |
GO:1901079 |
positive regulation of relaxation of muscle(GO:1901079) |
| 0.1 |
0.1 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
0.8 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.1 |
1.4 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.1 |
0.1 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.1 |
2.2 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.1 |
0.5 |
GO:0060290 |
transdifferentiation(GO:0060290) |
| 0.1 |
0.1 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.1 |
0.6 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.1 |
0.4 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.5 |
GO:2000568 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 |
3.2 |
GO:0007289 |
spermatid nucleus differentiation(GO:0007289) |
| 0.1 |
0.5 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.1 |
1.3 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 |
0.7 |
GO:0048565 |
digestive tract development(GO:0048565) |
| 0.1 |
0.2 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.1 |
0.2 |
GO:1903224 |
regulation of endodermal cell differentiation(GO:1903224) |
| 0.1 |
0.3 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.1 |
0.6 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 |
0.2 |
GO:0033091 |
positive regulation of immature T cell proliferation(GO:0033091) |
| 0.1 |
0.3 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
0.1 |
GO:1903490 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.1 |
1.0 |
GO:0001845 |
phagolysosome assembly(GO:0001845) |
| 0.1 |
0.3 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) |
| 0.1 |
0.2 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.1 |
0.3 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 |
2.3 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.1 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 |
0.2 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 |
0.5 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.1 |
0.3 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.1 |
2.5 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.1 |
0.6 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 |
1.5 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
0.3 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
0.5 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.1 |
0.7 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.1 |
0.2 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
1.8 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.1 |
0.2 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.1 |
0.2 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
| 0.1 |
0.1 |
GO:0032730 |
positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.1 |
0.9 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.1 |
0.6 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.3 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.1 |
0.3 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 |
0.4 |
GO:1903969 |
mammary gland fat development(GO:0060611) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) regulation of response to macrophage colony-stimulating factor(GO:1903969) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 0.1 |
0.2 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
| 0.1 |
1.7 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.2 |
GO:0035963 |
cellular response to interleukin-13(GO:0035963) |
| 0.1 |
1.0 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.3 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 0.1 |
0.1 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.1 |
0.2 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 |
5.5 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.1 |
0.9 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.1 |
0.5 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.1 |
0.6 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
0.6 |
GO:1903358 |
regulation of Golgi organization(GO:1903358) |
| 0.1 |
0.2 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
1.8 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 |
0.5 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.1 |
0.2 |
GO:0033146 |
regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
| 0.1 |
0.3 |
GO:0045957 |
regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 0.1 |
0.2 |
GO:0007567 |
parturition(GO:0007567) |
| 0.1 |
3.2 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 |
0.1 |
GO:2000857 |
positive regulation of corticosteroid hormone secretion(GO:2000848) positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 |
0.1 |
GO:0007612 |
learning(GO:0007612) |
| 0.1 |
0.2 |
GO:0018352 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 |
0.4 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.1 |
1.1 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 |
1.2 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.1 |
0.2 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.1 |
0.4 |
GO:0071877 |
regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.1 |
0.3 |
GO:0090258 |
negative regulation of mitochondrial fission(GO:0090258) |
| 0.1 |
0.2 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 |
0.8 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.5 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 |
0.2 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.5 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.1 |
0.8 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.1 |
3.9 |
GO:2000249 |
regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.1 |
0.1 |
GO:0045738 |
negative regulation of DNA repair(GO:0045738) |
| 0.1 |
0.7 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
0.1 |
GO:0051216 |
cartilage development(GO:0051216) |
| 0.1 |
0.7 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.1 |
0.3 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.3 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.1 |
0.4 |
GO:0060148 |
positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.1 |
1.5 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.1 |
0.2 |
GO:0060137 |
maternal process involved in parturition(GO:0060137) |
| 0.1 |
0.4 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.1 |
4.6 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 |
0.4 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
1.4 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.1 |
1.3 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 |
0.3 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.5 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.1 |
0.2 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 0.1 |
2.0 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 |
0.1 |
GO:0090307 |
mitotic spindle assembly(GO:0090307) |
| 0.1 |
4.9 |
GO:0003254 |
regulation of membrane depolarization(GO:0003254) |
| 0.1 |
0.3 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 |
0.7 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.5 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.4 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.1 |
0.9 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
0.3 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.1 |
0.4 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.1 |
0.1 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.1 |
0.4 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.1 |
0.7 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.1 |
1.4 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.1 |
0.1 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.3 |
GO:0050976 |
detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.1 |
0.5 |
GO:1902866 |
regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 |
1.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.1 |
0.2 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 0.1 |
0.5 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.1 |
0.5 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.1 |
0.4 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 |
0.4 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
0.2 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 0.1 |
1.8 |
GO:0001556 |
oocyte maturation(GO:0001556) |
| 0.1 |
0.5 |
GO:0060600 |
dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.1 |
1.4 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.1 |
1.1 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 |
0.8 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.2 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.1 |
0.1 |
GO:0055017 |
cardiac muscle tissue growth(GO:0055017) |
| 0.1 |
0.2 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.1 |
0.1 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 |
0.3 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
| 0.1 |
0.2 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
3.3 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.1 |
0.3 |
GO:0046125 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 |
0.2 |
GO:2000097 |
smooth muscle cell-matrix adhesion(GO:0061302) regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.1 |
0.8 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.1 |
0.4 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.1 |
0.1 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.1 |
0.1 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.1 |
0.3 |
GO:0060264 |
respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) positive regulation of respiratory burst involved in inflammatory response(GO:0060265) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.1 |
0.1 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 |
0.5 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 0.1 |
0.4 |
GO:0010816 |
neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 |
0.2 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
0.1 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
| 0.1 |
0.1 |
GO:0060699 |
regulation of endoribonuclease activity(GO:0060699) |
| 0.1 |
1.1 |
GO:0002098 |
tRNA wobble uridine modification(GO:0002098) |
| 0.1 |
0.3 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.1 |
0.2 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 0.1 |
1.1 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.1 |
0.7 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.1 |
0.1 |
GO:0006565 |
L-serine catabolic process(GO:0006565) |
| 0.1 |
1.2 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 |
5.8 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 |
0.3 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.1 |
0.1 |
GO:0032095 |
regulation of response to food(GO:0032095) |
| 0.1 |
0.1 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.1 |
0.2 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.1 |
2.8 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.1 |
0.2 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.5 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
1.1 |
GO:0045187 |
regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.1 |
0.3 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.1 |
2.4 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.1 |
0.5 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.1 |
1.0 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
0.1 |
GO:0048841 |
regulation of axon extension involved in axon guidance(GO:0048841) |
| 0.1 |
0.5 |
GO:0002767 |
immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.1 |
0.2 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.1 |
0.5 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.1 |
0.5 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.4 |
GO:0072719 |
cellular response to cisplatin(GO:0072719) |
| 0.1 |
1.4 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
0.4 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) inositol phosphate-mediated signaling(GO:0048016) |
| 0.1 |
0.9 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.4 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 |
0.3 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.1 |
0.6 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.1 |
0.2 |
GO:0034698 |
response to follicle-stimulating hormone(GO:0032354) response to gonadotropin(GO:0034698) |
| 0.1 |
0.2 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.1 |
0.4 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.1 |
0.5 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.3 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.3 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.2 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.1 |
0.4 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.2 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.1 |
0.3 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.1 |
0.1 |
GO:1903429 |
regulation of cell maturation(GO:1903429) |
| 0.1 |
0.2 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 |
0.4 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.3 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.1 |
0.2 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.1 |
0.3 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.1 |
0.8 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.2 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.1 |
0.1 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.1 |
0.5 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.1 |
2.7 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.1 |
0.3 |
GO:0007343 |
egg activation(GO:0007343) |
| 0.1 |
0.8 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.7 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.1 |
1.0 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.1 |
0.1 |
GO:1901655 |
cellular response to ketone(GO:1901655) |
| 0.1 |
0.3 |
GO:0003100 |
regulation of systemic arterial blood pressure by endothelin(GO:0003100) vein smooth muscle contraction(GO:0014826) |
| 0.1 |
0.3 |
GO:0010642 |
negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.1 |
0.1 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.1 |
1.0 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.3 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.1 |
0.9 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.1 |
0.3 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
| 0.1 |
0.8 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.1 |
1.5 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.1 |
0.6 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
0.2 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.1 |
0.7 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
0.4 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 |
0.3 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
0.3 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.1 |
2.0 |
GO:0014046 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 |
1.7 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.1 |
GO:0060920 |
cardiac pacemaker cell differentiation(GO:0060920) |
| 0.1 |
0.9 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.1 |
GO:0042745 |
circadian sleep/wake cycle(GO:0042745) |
| 0.1 |
0.3 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.2 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.1 |
0.7 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.2 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.1 |
0.3 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
0.9 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 |
0.2 |
GO:1904729 |
negative regulation of intestinal phytosterol absorption(GO:0010949) regulation of intestinal cholesterol absorption(GO:0030300) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) regulation of intestinal lipid absorption(GO:1904729) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.1 |
2.7 |
GO:1902808 |
positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.1 |
0.2 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.4 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.1 |
0.3 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.1 |
1.1 |
GO:0032196 |
transposition(GO:0032196) |
| 0.1 |
6.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
0.2 |
GO:0036512 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.1 |
0.5 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.1 |
0.1 |
GO:0001759 |
organ induction(GO:0001759) |
| 0.1 |
0.6 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.1 |
1.0 |
GO:0046135 |
pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 |
0.6 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 |
0.4 |
GO:0019556 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.1 |
0.6 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 |
0.2 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.1 |
0.3 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.1 |
0.1 |
GO:1902310 |
positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 |
0.4 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.1 |
0.1 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.1 |
0.2 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.1 |
0.7 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
0.5 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.2 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.1 |
0.3 |
GO:0055014 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 |
0.2 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.1 |
0.3 |
GO:0072367 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.1 |
0.4 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.1 |
0.2 |
GO:0010042 |
response to manganese ion(GO:0010042) |
| 0.1 |
0.3 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
0.2 |
GO:0033078 |
extrathymic T cell differentiation(GO:0033078) |
| 0.1 |
0.3 |
GO:0000717 |
nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.1 |
0.5 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.8 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
0.2 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.1 |
0.4 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.1 |
0.2 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.1 |
0.4 |
GO:0060696 |
regulation of phospholipid catabolic process(GO:0060696) |
| 0.1 |
0.8 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.2 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.1 |
0.9 |
GO:1990118 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 |
0.3 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.3 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.1 |
0.7 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.1 |
0.3 |
GO:1902745 |
positive regulation of lamellipodium organization(GO:1902745) |
| 0.1 |
0.1 |
GO:1904154 |
trimming of terminal mannose on C branch(GO:0036510) positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 |
0.4 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.6 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.1 |
0.1 |
GO:0015908 |
fatty acid transport(GO:0015908) |
| 0.1 |
0.2 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.1 |
0.1 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
0.4 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.1 |
0.3 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.1 |
0.1 |
GO:0033605 |
positive regulation of norepinephrine secretion(GO:0010701) positive regulation of catecholamine secretion(GO:0033605) |
| 0.1 |
0.1 |
GO:1902744 |
negative regulation of lamellipodium organization(GO:1902744) |
| 0.1 |
0.9 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.2 |
GO:0071030 |
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.1 |
0.4 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.1 |
0.1 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) formaldehyde catabolic process(GO:0046294) |
| 0.1 |
0.2 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
2.6 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.1 |
0.6 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.1 |
0.1 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.1 |
0.3 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 |
0.1 |
GO:0052405 |
negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.1 |
3.8 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
1.8 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.3 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
2.2 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.1 |
0.2 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.1 |
0.9 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.1 |
0.1 |
GO:0002428 |
antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
| 0.1 |
0.2 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
0.8 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 |
3.0 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) |
| 0.1 |
1.6 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
0.3 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.1 |
0.3 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
1.0 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 |
0.1 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.1 |
0.3 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
0.3 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.1 |
0.7 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.1 |
0.3 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.1 |
0.7 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.2 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 |
0.2 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.1 |
0.3 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 |
0.3 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.1 |
1.1 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 |
0.7 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 |
0.1 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.1 |
0.2 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.1 |
0.2 |
GO:0072579 |
molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.1 |
2.0 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.1 |
0.5 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.3 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
0.2 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.1 |
0.1 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.1 |
0.1 |
GO:0015801 |
aromatic amino acid transport(GO:0015801) |
| 0.1 |
0.3 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.3 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 |
0.6 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
0.3 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.1 |
0.1 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.1 |
0.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.3 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 0.1 |
0.1 |
GO:0006425 |
glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.1 |
0.3 |
GO:0044571 |
[2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 |
1.2 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.1 |
1.2 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
1.1 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.1 |
0.1 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.1 |
0.2 |
GO:0009071 |
serine family amino acid catabolic process(GO:0009071) |
| 0.1 |
0.3 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
0.4 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.1 |
0.3 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 |
0.3 |
GO:0072025 |
distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.1 |
0.5 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.1 |
0.2 |
GO:0045978 |
negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
| 0.1 |
0.4 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 |
0.1 |
GO:0071709 |
membrane assembly(GO:0071709) |
| 0.1 |
0.1 |
GO:0036490 |
regulation of translation in response to endoplasmic reticulum stress(GO:0036490) |
| 0.1 |
0.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.2 |
GO:1903566 |
positive regulation of protein localization to cilium(GO:1903566) |
| 0.1 |
0.2 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.3 |
GO:0033189 |
response to vitamin A(GO:0033189) |
| 0.1 |
0.2 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.1 |
0.2 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.1 |
0.7 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.4 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
0.1 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.1 |
0.3 |
GO:0060356 |
tryptophan transport(GO:0015827) leucine import(GO:0060356) |
| 0.1 |
0.1 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) aromatic amino acid family metabolic process(GO:0009072) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 |
2.1 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.2 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 |
0.3 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.3 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
0.1 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 |
0.7 |
GO:0042446 |
hormone biosynthetic process(GO:0042446) |
| 0.1 |
0.1 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.1 |
1.7 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.1 |
1.0 |
GO:2000345 |
regulation of hepatocyte proliferation(GO:2000345) |
| 0.1 |
0.1 |
GO:1900248 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 |
0.5 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.1 |
0.2 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.3 |
GO:0043536 |
positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 |
0.7 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.1 |
0.1 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.1 |
0.8 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.1 |
0.1 |
GO:0009217 |
purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
| 0.1 |
0.1 |
GO:0032224 |
positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.1 |
0.7 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 |
0.2 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
0.1 |
GO:0021586 |
pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.1 |
1.3 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.1 |
0.1 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.1 |
0.3 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.1 |
0.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 |
0.2 |
GO:0035641 |
locomotory exploration behavior(GO:0035641) |
| 0.1 |
0.4 |
GO:0043320 |
natural killer cell degranulation(GO:0043320) |
| 0.1 |
0.1 |
GO:0051714 |
positive regulation of cytolysis in other organism(GO:0051714) |
| 0.1 |
0.2 |
GO:0060071 |
Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
| 0.1 |
0.8 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.1 |
0.2 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.1 |
0.2 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
0.1 |
GO:1904429 |
regulation of t-circle formation(GO:1904429) |
| 0.1 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.1 |
GO:0019401 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.1 |
0.9 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
0.2 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 |
0.2 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 0.1 |
0.5 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.1 |
2.5 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
0.1 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 |
0.4 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 |
0.3 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.1 |
0.8 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.1 |
0.4 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 |
0.1 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.1 |
0.8 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.1 |
0.2 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.1 |
0.5 |
GO:0034656 |
nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.1 |
0.2 |
GO:2000342 |
negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 |
1.3 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.1 |
0.2 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.1 |
1.6 |
GO:0072431 |
signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
| 0.1 |
0.8 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.1 |
0.1 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.1 |
0.1 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.1 |
0.6 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.1 |
0.4 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 |
0.1 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.1 |
0.4 |
GO:0035588 |
G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.1 |
0.3 |
GO:2000323 |
negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.1 |
1.2 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 |
0.1 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
0.7 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.5 |
GO:0071498 |
cellular response to fluid shear stress(GO:0071498) |
| 0.1 |
0.2 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.1 |
3.8 |
GO:0000079 |
regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.1 |
0.2 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.1 |
0.3 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 |
0.2 |
GO:0051957 |
positive regulation of amine transport(GO:0051954) positive regulation of amino acid transport(GO:0051957) |
| 0.1 |
0.2 |
GO:0048806 |
genitalia development(GO:0048806) |
| 0.1 |
0.6 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.8 |
GO:0001953 |
negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.1 |
0.1 |
GO:0071469 |
cellular response to alkaline pH(GO:0071469) |
| 0.1 |
0.2 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.1 |
0.1 |
GO:0001508 |
action potential(GO:0001508) |
| 0.0 |
0.1 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.0 |
0.0 |
GO:0000393 |
spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.0 |
0.2 |
GO:0090043 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.3 |
GO:0035878 |
nail development(GO:0035878) |
| 0.0 |
0.3 |
GO:1900004 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.0 |
0.7 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.0 |
0.5 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.0 |
0.1 |
GO:0071504 |
cellular response to heparin(GO:0071504) |
| 0.0 |
0.0 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.6 |
GO:0018027 |
peptidyl-lysine dimethylation(GO:0018027) |
| 0.0 |
0.2 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
1.3 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.0 |
0.2 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.0 |
0.1 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 |
0.0 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.0 |
1.2 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.0 |
0.4 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.0 |
0.1 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.0 |
0.1 |
GO:0006210 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.0 |
0.8 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.0 |
0.9 |
GO:0048385 |
regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 0.0 |
1.6 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.3 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 |
1.0 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.0 |
0.4 |
GO:0015837 |
amine transport(GO:0015837) |
| 0.0 |
1.6 |
GO:0043928 |
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.4 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.0 |
0.1 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.0 |
0.4 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.0 |
0.3 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.2 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.0 |
0.0 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) |
| 0.0 |
1.7 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.1 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.0 |
0.0 |
GO:0045906 |
negative regulation of vasoconstriction(GO:0045906) |
| 0.0 |
0.5 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.0 |
0.0 |
GO:0043313 |
regulation of neutrophil degranulation(GO:0043313) |
| 0.0 |
0.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.4 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.0 |
0.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 |
0.4 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.1 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.0 |
0.0 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.0 |
0.1 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.0 |
0.1 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.1 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.0 |
0.1 |
GO:0048041 |
cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
| 0.0 |
2.1 |
GO:0035036 |
sperm-egg recognition(GO:0035036) |
| 0.0 |
0.1 |
GO:0061582 |
intestinal epithelial cell migration(GO:0061582) |
| 0.0 |
0.3 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 |
0.2 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
| 0.0 |
0.1 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.1 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.0 |
0.3 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 |
2.0 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
0.6 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.0 |
0.2 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.0 |
0.2 |
GO:0071354 |
cellular response to interleukin-6(GO:0071354) |
| 0.0 |
0.2 |
GO:0006970 |
response to osmotic stress(GO:0006970) |
| 0.0 |
0.2 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.5 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 |
0.1 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.5 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.0 |
0.0 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.0 |
0.3 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 |
0.1 |
GO:0032679 |
TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.0 |
0.3 |
GO:1901098 |
positive regulation of autophagosome maturation(GO:1901098) |
| 0.0 |
0.2 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.2 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.0 |
0.2 |
GO:0050942 |
positive regulation of pigment cell differentiation(GO:0050942) |
| 0.0 |
0.1 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.0 |
0.2 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.0 |
0.2 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.0 |
0.2 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.0 |
0.2 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.0 |
0.1 |
GO:0044843 |
cell cycle G1/S phase transition(GO:0044843) |
| 0.0 |
0.2 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) |
| 0.0 |
0.1 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.0 |
0.3 |
GO:0032720 |
negative regulation of tumor necrosis factor production(GO:0032720) |
| 0.0 |
0.2 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 |
0.0 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 |
0.2 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.0 |
0.2 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.0 |
0.2 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.0 |
0.5 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.0 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.0 |
0.5 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.7 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
2.5 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.0 |
0.1 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.0 |
0.6 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.0 |
0.1 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 |
0.2 |
GO:0001555 |
oocyte growth(GO:0001555) |
| 0.0 |
0.1 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.0 |
0.0 |
GO:0043650 |
dicarboxylic acid biosynthetic process(GO:0043650) |
| 0.0 |
0.6 |
GO:0046475 |
glycerophospholipid catabolic process(GO:0046475) |
| 0.0 |
0.4 |
GO:0009304 |
tRNA transcription(GO:0009304) |
| 0.0 |
0.2 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.0 |
0.1 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.0 |
0.1 |
GO:0032532 |
regulation of microvillus length(GO:0032532) |
| 0.0 |
1.0 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 |
0.3 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.0 |
0.1 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 |
0.1 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 0.0 |
0.5 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 |
0.1 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.0 |
0.4 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 |
0.0 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.0 |
0.1 |
GO:1901970 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.0 |
0.3 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.0 |
0.2 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.5 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.1 |
GO:0080154 |
regulation of fertilization(GO:0080154) |
| 0.0 |
0.2 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.2 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.0 |
0.1 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.0 |
0.1 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.0 |
0.2 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.0 |
0.0 |
GO:1903902 |
positive regulation of viral life cycle(GO:1903902) |
| 0.0 |
0.9 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.0 |
0.5 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.0 |
0.1 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.0 |
0.1 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.0 |
0.0 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) |
| 0.0 |
0.9 |
GO:0043627 |
response to estrogen(GO:0043627) |
| 0.0 |
0.1 |
GO:0033044 |
regulation of chromosome organization(GO:0033044) |
| 0.0 |
0.1 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.0 |
1.8 |
GO:0019730 |
antimicrobial humoral response(GO:0019730) |
| 0.0 |
0.1 |
GO:1901856 |
negative regulation of cellular respiration(GO:1901856) |
| 0.0 |
0.1 |
GO:0051446 |
positive regulation of meiotic nuclear division(GO:0045836) positive regulation of meiotic cell cycle(GO:0051446) |
| 0.0 |
0.2 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.0 |
0.0 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.0 |
0.0 |
GO:0014824 |
artery smooth muscle contraction(GO:0014824) |
| 0.0 |
1.7 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.0 |
0.1 |
GO:0034101 |
erythrocyte homeostasis(GO:0034101) |
| 0.0 |
0.1 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.0 |
0.2 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.0 |
0.2 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.0 |
0.2 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 |
0.9 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.1 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 |
0.1 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.0 |
0.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.0 |
0.3 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 |
0.5 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 |
0.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.0 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 |
0.1 |
GO:0051106 |
positive regulation of DNA ligation(GO:0051106) |
| 0.0 |
0.2 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 |
0.2 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.0 |
0.2 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.0 |
0.1 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.0 |
0.1 |
GO:1902743 |
regulation of lamellipodium organization(GO:1902743) |
| 0.0 |
0.0 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.0 |
0.1 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 |
0.0 |
GO:0032640 |
tumor necrosis factor production(GO:0032640) |
| 0.0 |
0.3 |
GO:0018022 |
peptidyl-lysine methylation(GO:0018022) |
| 0.0 |
1.4 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.6 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.2 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 |
1.2 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 |
4.5 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.2 |
GO:0032438 |
melanosome organization(GO:0032438) |
| 0.0 |
0.2 |
GO:0014829 |
vascular smooth muscle contraction(GO:0014829) |
| 0.0 |
0.1 |
GO:0009106 |
lipoate metabolic process(GO:0009106) lipoate biosynthetic process(GO:0009107) |
| 0.0 |
0.2 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.0 |
0.2 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.0 |
0.1 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.0 |
0.1 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.0 |
0.2 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 |
0.6 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.1 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.0 |
0.0 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.0 |
0.1 |
GO:0043031 |
negative regulation of macrophage activation(GO:0043031) |
| 0.0 |
0.5 |
GO:0042462 |
eye photoreceptor cell development(GO:0042462) |
| 0.0 |
1.7 |
GO:0001523 |
retinoid metabolic process(GO:0001523) |
| 0.0 |
0.1 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 |
0.2 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
1.7 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.6 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.1 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.0 |
0.1 |
GO:0048675 |
axon extension(GO:0048675) |
| 0.0 |
0.0 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.0 |
0.0 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.0 |
0.0 |
GO:2000765 |
regulation of cytoplasmic translation(GO:2000765) |
| 0.0 |
1.6 |
GO:0044070 |
regulation of anion transport(GO:0044070) |
| 0.0 |
0.3 |
GO:0001941 |
postsynaptic membrane organization(GO:0001941) |
| 0.0 |
0.1 |
GO:0002818 |
intracellular defense response(GO:0002818) |
| 0.0 |
0.1 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.4 |
GO:0009755 |
hormone-mediated signaling pathway(GO:0009755) |
| 0.0 |
0.1 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.0 |
0.0 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.0 |
0.2 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.1 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.0 |
0.5 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.0 |
0.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.0 |
0.1 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.0 |
0.2 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.1 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.0 |
0.1 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.0 |
0.1 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.0 |
0.8 |
GO:0030834 |
regulation of actin filament depolymerization(GO:0030834) |
| 0.0 |
0.1 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 |
0.2 |
GO:0090481 |
pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.0 |
0.1 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.1 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.0 |
0.3 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.1 |
GO:1904350 |
regulation of protein catabolic process in the vacuole(GO:1904350) positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.0 |
0.1 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.0 |
0.1 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.0 |
0.2 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.0 |
0.1 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.0 |
0.8 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.1 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
0.4 |
GO:0006734 |
NADH metabolic process(GO:0006734) |
| 0.0 |
0.1 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.0 |
0.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 |
0.0 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.1 |
GO:0046035 |
CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 |
0.2 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.0 |
0.0 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.0 |
0.2 |
GO:0008037 |
cell recognition(GO:0008037) |
| 0.0 |
0.1 |
GO:0017145 |
stem cell division(GO:0017145) |
| 0.0 |
0.0 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.0 |
0.3 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.0 |
0.3 |
GO:0042921 |
glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.0 |
0.4 |
GO:0030516 |
regulation of axon extension(GO:0030516) |
| 0.0 |
0.4 |
GO:0030048 |
actin filament-based movement(GO:0030048) |
| 0.0 |
0.9 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.3 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.0 |
0.1 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.0 |
0.1 |
GO:0052696 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 |
0.2 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.0 |
0.1 |
GO:0048483 |
autonomic nervous system development(GO:0048483) |
| 0.0 |
0.1 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.0 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.0 |
0.1 |
GO:0090342 |
regulation of cell aging(GO:0090342) |
| 0.0 |
1.2 |
GO:0036498 |
IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 |
0.1 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.0 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.0 |
0.1 |
GO:0043380 |
memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) |
| 0.0 |
0.1 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 |
0.0 |
GO:0090303 |
positive regulation of wound healing(GO:0090303) |
| 0.0 |
0.2 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.0 |
0.2 |
GO:0007135 |
meiosis II(GO:0007135) |
| 0.0 |
0.1 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 |
0.1 |
GO:1990564 |
protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.0 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.0 |
0.1 |
GO:1900116 |
extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 |
0.1 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.0 |
0.2 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
1.4 |
GO:0009301 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 |
0.3 |
GO:0045616 |
regulation of keratinocyte differentiation(GO:0045616) |
| 0.0 |
0.3 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.0 |
0.1 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
| 0.0 |
0.5 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.2 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.1 |
GO:0000019 |
regulation of mitotic recombination(GO:0000019) |
| 0.0 |
0.1 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 |
0.4 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.0 |
0.0 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 |
0.1 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.0 |
0.3 |
GO:1901642 |
nucleoside transmembrane transport(GO:1901642) |
| 0.0 |
0.1 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.0 |
0.2 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.0 |
0.1 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.0 |
0.0 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.1 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.0 |
0.1 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 |
0.1 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.0 |
0.0 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) |
| 0.0 |
0.2 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.0 |
0.0 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.1 |
GO:0050703 |
interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
| 0.0 |
0.0 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.0 |
0.4 |
GO:0005980 |
glycogen catabolic process(GO:0005980) |
| 0.0 |
0.1 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.0 |
0.4 |
GO:0002028 |
regulation of sodium ion transport(GO:0002028) |
| 0.0 |
0.1 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 |
0.2 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.0 |
0.0 |
GO:1904292 |
regulation of ERAD pathway(GO:1904292) |
| 0.0 |
0.2 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.0 |
0.5 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.0 |
0.1 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.5 |
GO:0006909 |
phagocytosis(GO:0006909) |
| 0.0 |
0.1 |
GO:0048865 |
stem cell fate commitment(GO:0048865) |
| 0.0 |
0.1 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
0.1 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.1 |
GO:1901052 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.0 |
0.1 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 |
0.0 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
| 0.0 |
0.9 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.3 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
0.2 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.0 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.0 |
0.1 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
0.0 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 |
0.0 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.0 |
0.1 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.0 |
0.0 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
0.8 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.1 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.0 |
0.0 |
GO:2000678 |
negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.0 |
0.2 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.1 |
GO:0098787 |
mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.0 |
0.1 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 |
0.0 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.0 |
0.0 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.0 |
0.1 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.0 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.0 |
0.1 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.0 |
1.1 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.0 |
0.1 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.0 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.0 |
0.2 |
GO:0019674 |
NAD metabolic process(GO:0019674) |
| 0.0 |
0.0 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.0 |
0.1 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.0 |
0.1 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.0 |
0.1 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.0 |
0.0 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.0 |
0.0 |
GO:0044806 |
G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 |
0.2 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 |
0.1 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.0 |
0.1 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.4 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.0 |
0.0 |
GO:0001825 |
blastocyst formation(GO:0001825) trophectodermal cell differentiation(GO:0001829) |
| 0.0 |
0.0 |
GO:0010212 |
response to ionizing radiation(GO:0010212) |
| 0.0 |
0.2 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.2 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
0.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.4 |
GO:0006939 |
smooth muscle contraction(GO:0006939) |
| 0.0 |
0.0 |
GO:0051351 |
regulation of ligase activity(GO:0051340) positive regulation of ligase activity(GO:0051351) |
| 0.0 |
0.1 |
GO:0070972 |
protein localization to endoplasmic reticulum(GO:0070972) |
| 0.0 |
0.2 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 |
0.1 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.0 |
0.1 |
GO:0051354 |
negative regulation of oxidoreductase activity(GO:0051354) |
| 0.0 |
0.0 |
GO:0010888 |
negative regulation of lipid storage(GO:0010888) |
| 0.0 |
0.1 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 |
1.8 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.0 |
0.0 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
0.1 |
GO:0051875 |
melanosome localization(GO:0032400) establishment of melanosome localization(GO:0032401) pigment granule localization(GO:0051875) establishment of pigment granule localization(GO:0051905) |
| 0.0 |
0.3 |
GO:2000117 |
negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.0 |
0.1 |
GO:0050432 |
catecholamine secretion(GO:0050432) |
| 0.0 |
0.0 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.0 |
0.1 |
GO:0061756 |
leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.0 |
0.3 |
GO:1902803 |
regulation of synaptic vesicle transport(GO:1902803) |
| 0.0 |
0.3 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 |
0.0 |
GO:1990637 |
response to prolactin(GO:1990637) |
| 0.0 |
4.9 |
GO:0007264 |
small GTPase mediated signal transduction(GO:0007264) |
| 0.0 |
0.0 |
GO:0014034 |
neural crest cell fate commitment(GO:0014034) |
| 0.0 |
0.0 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 |
0.1 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.0 |
0.6 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.0 |
GO:0006568 |
tryptophan metabolic process(GO:0006568) |
| 0.0 |
0.1 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.1 |
GO:0003298 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.2 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.0 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.0 |
0.0 |
GO:0021612 |
facial nerve structural organization(GO:0021612) |
| 0.0 |
0.0 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 |
0.3 |
GO:0007204 |
positive regulation of cytosolic calcium ion concentration(GO:0007204) |
